HealthcareJul 18, 2026

Arbor Pharmaceuticals, LLC

Company Profile Analysis

Book Demo Subscribe Now

Arbor Pharmaceuticals, LLC - Healthcare showcase

Year Founded & Workforce

2012-12-31

400 Employees

Industry

Healthcare

Services

Arbor Pharmaceuticals, LLC Overview

Company Headquarters: Georgia, US

Founded: 2013

Workforce: ~400

Company Working: Arbor Pharmaceuticals, LLC (Arbor Pharmaceuticals) is a specialty pharmaceutical company based in the US that researches, develops, manufactures, and commercializes prescription products. The company operates through hospital & specialty, cardiology, neuroscience, pediatrics, and legacy & generics businesses. Gliadel is a registered trademark of Eisai Inc. and is manufactured by Eisai Inc., for Arbor Pharmaceuticals. The company markets various generic prescription products through its Wilshire division and has over a dozen abbreviated new drug applications (ANDAs) on file with the FDA and many others in different stages of development. The company produces novel chemical entities and previously approved molecules for new indications or in improved dosage forms.

Strategy

Arbor Pharmaceuticals focuses on collaborations with many of the local universities and discovery centers to identify innovations in the pharmaceuticals industry. Currently, the company is strongly emphasizing research & development (R&D) wherein; it has filed four new drug applications (NDAs), which have been approved by the FDA and has several additional products in late-stage development.

Company Snapshot

400

Employees

2012-12-31

Founded

Georgia, US

Headquarters

SWOT Analysis

Strengths

Robust R&D capabilities
Strong employee base

Weaknesses

Limited product portfolio
Insufficient geographical presence

Opportunities

Product portfolio expansion
Worldwide expansion

Threats

Increasing competition from other pharmaceutical companies
Price fluctuations

Key Developments

Date	Approach	Development
–	Product Launch	Eisai Group launched Gliadel in Mexico for the treatment of patients with recurrent glioblastoma multiforme as an adjunct to surgery.

Product Offering

Arbor Pharmaceuticals, LLC
- Chemotherapy

A plan for every need

Forecast+

Get unlimited access to forecasts, charts, and company data across every research report on Wantstats.

USD200/mo

About the Author

Wantstats Research Team

Wantstats' research desk profiles Arbor Pharmaceuticals, LLC as part of our ongoing coverage of the Healthcare sector, drawing on public company data, filings, and market intelligence.

Powering the world's best teams.
From next-gen startups to established enterprises.

See our work in action

Start your data driven journey with us!

Book a Demo Now

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

Arbor Pharmaceuticals, LLC

Company Headquarters: Georgia, US Founded: 2013 Workforce: ~400 Company Working: Arbor Pharmaceuticals, LLC (Arbor Pharmaceuticals) is a specialty pharmaceutical company based in the US that researches, develops, manufactures, and commercializes prescription products. The company operates through hospital & specialty, cardiology, neuroscience, pediatrics, and legacy & generics businesses. Gliadel is a registered trademark of Eisai Inc. and is manufactured by Eisai Inc., for Arbor Pharmaceuticals. The company markets various generic prescription products through its Wilshire division and has over a dozen abbreviated new drug applications (ANDAs) on file with the FDA and many others in different stages of development. The company produces novel chemical entities and previously approved molecules for new indications or in improved dosage forms.

Starting from

$4,950